startup

MiRdetect

MiRdetect creates innovative in vitro diagnostic kits.
  • Life Science & Healthcare
  • Seed Stage
  • Other
  • B2B
  • 2016
  • 1-10 Employees
  • Found
  • Bremerhaven, DE
  • mirdetect.de
  • miRdetect GmbH
  • Bremen

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile

About the company

MiRdetect GmbH is a biotechnology company founded with the vision to revolutionize cancer diagnostics. The focus is on the development, production and distribution of in-vitro diagnostics based on molecular diagnostic methods. The first product, based on the detection of microRNA, is a blood test for the detection of testicular cancer. The high sensitivity and accuracy significantly improve the diagnosis and therapy of patients and reduce costs in the healthcare system. The platform technology developed and patented by miRdetect enables the precise and reliable detection of very small amounts of genetic material in body fluids. This robust procedure forms the basis for the development of further tests.

MiRdetect Funding

Management

Nina Winter Geschäftsführerin
since 2015

Alumni

2015 - 2016
1 years, 1 months
Kerstin Lucht-Hübner
Geschäftsführerin
2016 - 2020
4 years, 5 months
Meike Spiekermann
Geschäftsführerin

News about MiRdetect

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen